Weight-loss danger
July 9, 2010
US patients taking Que She, a
herbal weight-loss supplement,
have been warned to immediately
cease use and seek the advice of a
doctor, after the Food and Drug
Administration discovered that not
all of the product’s ingredients were
listed on the pack.
The FDA has warned that some
of the unlisted ingredients may
have harmful effects, particularly on
those that suffer from
cardiovascular conditions.
Unlisted ingredients featuring in
the Que She recipe include
fenfluramine (a stimulant drug
withdrawn from the US market in
1997 after studies demonstrated
that it caused serious heart valve
damage) and propranolol (a
prescription-only beta blocker drug
that can pose a risk to people with
bronchial asthma and certain
heart conditions)
Further unlisted ingredients
include ephedrine (a stimulant
drug that is legally marketed overthe-
counter for temporary relief of
asthma but can pose a risk to
people with certain cardiovascular
conditions) and sibutramine (a
controlled substance, sibutramine
was the subject of a study whose
findings showed an association
between its usage and increased
risk of heart attack and stroke).
The FDA has also said that
consumers need to be doubly
cautious, as the unlisted
ingredients are also likely to
interact with other medications.
Que She has not been approved
for use in Australia via the ARTG,
however it is a widely available and
popular weight-loss product
available for sale via many internet
websites.
For info see www.fda.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jul 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jul 10
